Genzyme Ltd: alleged abuse of a dominant position
| Jurisdiction | UK Non-devolved |
| Court | Competition and Markets Authority (UK) |
| Case Outcome | CA98 - infringement Chapter II |
| Case Number | CA98/3/03 |
| Decision Date | 27 March 2003 |
| Date | 27 March 2003 |
| Published date | 27 March 2003 |
| topic | penalties ,pattern of infringements ,dispensation of medicine,competition law regulatory bodies ,fairness of trading,price competition,infringement evidence,office of fair trading |
| Subject Matter | CA98 and civil cartels |
Office of Fair Trading 1
Competition Act 1998
Decision of Director General of Fair Trading
No. CA98/3/03
Exclusionary behaviour by Genzyme Limited
27 March 2003
(Case CP/0488-01)
SUMMARY
The Director General of Fair Trading (the 'Director') has concluded that Genzyme
Limited ('Genzyme') has abused its dominant position in the market for the
supply of drugs for the treatment of Gaucher disease in the UK in breach of
section 18 (the 'Chapter II prohibition') of the Competition Act 1998 (the 'Act').
Genzyme supplies the NHS with Cerezyme, a drug for the treatment of Gaucher
disease. Gaucher disease is a rare inherited disorder. Genzyme has a dominant
position in the market for the supply of drugs for the treatment of Gaucher
disease.
Genzyme has abused its dominant position by making the NHS pay a price which
includes home delivery of Cerezyme and provision of homecare services if the
NHS wishes to purchase Cerezyme, and by adopting a pricing policy for
Cerezyme which results in a margin squeeze. The first practice began in the
early 1990s and it has constituted an infringement of the Act since the coming
into force of the Chapter II prohibition on 1 March 2000. The second
infringement began in May 2001 when Genzyme launched its own delivery and
homecare services operation and continued until the date of this Decision.
Genzyme’s behaviour has prevented any competition in home delivery of
Cerezyme and provision of homecare services, thereby reserving this activity to
Genzyme (or an undertaking acting under contract for it), and depriving the NHS
and patients of a choice of delivery/homecare services provider. By preventing
viable independent provision of delivery/homecare services for Cerezyme,
Genzyme’s behaviour has also raised barriers to entry into the market for the
Office of Fair Trading 2
supply of drugs for the treatment of Gaucher disease. The Director takes the
view that this behaviour has affected trade within the UK and is in breach of the
Chapter II prohibition.
The Director considers that Genzyme’s behaviour constitutes a serious
infringement of the Act. He is therefore imposing a financial penalty on
Genzyme of £6.8 million.
Office of Fair Trading 3
TABLE OF CONTENTS
I. INTRODUCTION .......................................................................................... 5
II. THE FACTS................................................................................................ 6
1. The Complaint...................................................................................... 6
2. The Undertaking ................................................................................... 8
(i) Genzyme................................................................................. 8
3. The product and services concerned ......................................................10
(i) The Product ...........................................................................10
(ii) The Services..........................................................................14
4. Specialised treatment of Gaucher disease in the UK .................................16
5. Regulatory Regime ...............................................................................17
(i) Legal requirements ..................................................................17
(ii) Orphan drugs......................................................................... 20
(iii) Pharmaceutical Price Regulation Scheme (PPRS) ........................23
(iv) The NHS list price and the PPRS..............................................25
(v) Pharmacy reimbursment..........................................................30
5. Pricing................................................................................................31
(i) NHS list price and hospital price................................................31
(ii) Payment for delivery and homecare services ..............................36
6. The current position .............................................................................40
III. LEGAL AND ECONOMIC ASSESSMENT .......................................................41
A. Dominance ............................................................................................42
1. Definition of dominance........................................................................ 42
2. Market definition .................................................................................42
(i) Relevant product market ..........................................................42
(ii) Relevant geographic market .....................................................63
3. Assessment of Dominance ....................................................................65
(i) The upstream market...............................................................66
(ii) The downstream market..........................................................91
4. Conclusion on dominance .....................................................................92
(i) The upstream market...............................................................92
(ii) The downstream market..........................................................92
Get this document and AI-powered insights with a free trial of vLex and Vincent AI
Get Started for FreeStart Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting
Start Your Free Trial of vLex and Vincent AI, Your Precision-Engineered Legal Assistant
-
Access comprehensive legal content with no limitations across vLex's unparalleled global legal database
-
Build stronger arguments with verified citations and CERT citator that tracks case history and precedential strength
-
Transform your legal research from hours to minutes with Vincent AI's intelligent search and analysis capabilities
-
Elevate your practice by focusing your expertise where it matters most while Vincent handles the heavy lifting